1. Home
  2. IMVT vs CNXC Comparison

IMVT vs CNXC Comparison

Compare IMVT & CNXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMVT
  • CNXC
  • Stock Information
  • Founded
  • IMVT 2018
  • CNXC 1991
  • Country
  • IMVT United States
  • CNXC United States
  • Employees
  • IMVT N/A
  • CNXC N/A
  • Industry
  • IMVT Biotechnology: Biological Products (No Diagnostic Substances)
  • CNXC Computer Software: Prepackaged Software
  • Sector
  • IMVT Health Care
  • CNXC Technology
  • Exchange
  • IMVT Nasdaq
  • CNXC Nasdaq
  • Market Cap
  • IMVT 2.7B
  • CNXC 3.0B
  • IPO Year
  • IMVT N/A
  • CNXC N/A
  • Fundamental
  • Price
  • IMVT $15.24
  • CNXC $52.07
  • Analyst Decision
  • IMVT Buy
  • CNXC Buy
  • Analyst Count
  • IMVT 11
  • CNXC 4
  • Target Price
  • IMVT $35.88
  • CNXC $68.75
  • AVG Volume (30 Days)
  • IMVT 1.2M
  • CNXC 644.6K
  • Earning Date
  • IMVT 08-11-2025
  • CNXC 09-24-2025
  • Dividend Yield
  • IMVT N/A
  • CNXC 2.55%
  • EPS Growth
  • IMVT N/A
  • CNXC N/A
  • EPS
  • IMVT N/A
  • CNXC 3.65
  • Revenue
  • IMVT N/A
  • CNXC $9,625,029,000.00
  • Revenue This Year
  • IMVT N/A
  • CNXC $3.66
  • Revenue Next Year
  • IMVT N/A
  • CNXC $3.20
  • P/E Ratio
  • IMVT N/A
  • CNXC $14.31
  • Revenue Growth
  • IMVT N/A
  • CNXC 11.31
  • 52 Week Low
  • IMVT $12.72
  • CNXC $36.28
  • 52 Week High
  • IMVT $34.47
  • CNXC $77.00
  • Technical
  • Relative Strength Index (RSI)
  • IMVT 43.58
  • CNXC 53.22
  • Support Level
  • IMVT $14.50
  • CNXC $48.39
  • Resistance Level
  • IMVT $15.52
  • CNXC $50.73
  • Average True Range (ATR)
  • IMVT 0.69
  • CNXC 1.98
  • MACD
  • IMVT -0.06
  • CNXC 0.55
  • Stochastic Oscillator
  • IMVT 41.16
  • CNXC 92.48

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

About CNXC Concentrix Corporation

Concentrix Corp is a technology enabled company specialized in customer engagement and customer management. The company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five industry verticals. The Company's verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Geographically, the company operates in Philippines, Unites States, India, Frances and Others. Maximum revenue is from Technology and consumer electronics industry and geographically from Philippines.

Share on Social Networks: